Start-ups 

FETCH 

Following the surge of available targeted therapies in metastatic cancer, there is an increasing need for the determination of treatment target expression.

FETCH obtains this information through the enrichment and characterization of tumour cells from the entire blood volume. Our low-invasive method results in a detailed molecular overview of the complete cancer, allowing both selection of existing and development of novel targeted treatments.

BioBusiness Masterclass

office@biobusinessmasterclass.nl